Clinical trial • Phase III • Infectious Disease
Clinical trial in Healthy volunteers
Phase III trial for Healthy volunteers. 90 participants.
Overview
- Trial Therapeutic Area
- Infectious Disease
- Trial Disease
- Healthy volunteers
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 27-09-2024
- First CTIS Authorization Date
- 29-10-2024
Trial design
Phase III trial across 1 site in Austria.
- Target Sample Size
- 90
Eligibility
Recruits 90 Vulnerable population not selected; no consent/assent details provided..
- Vulnerable Population
- Vulnerable population not selected; no consent/assent details provided.
Recruitment
- Planned Sample Size
- 90
- Recruitment Window Months
- 55
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 90
Austria
- Earliest CTIS Part Ii Submission Date
- 04-10-2024
- Latest Decision Or Authorization Date
- 06-11-2025
- Processing Time Days
- 398
- Number Of Sites
- 1
- Number Of Participants
- 90
Sites
- Site Name
- Waehringer Guertel 18-20, Alsergrund
- Department Name
- Department of Clinical Pharmacology
- Principal Investigator Name
- Markus Zeitlinger
- Principal Investigator Email
- markus.zeitlinger@meduniwien.ac.at
- Contact Person Name
- Markus Zeitlinger
- Contact Person Email
- markus.zeitlinger@meduniwien.ac.at
- Number Of Participants
- 90
Sponsor
Primary sponsor
- Full Name
- Medical University Of Vienna
- Organisation Type
- Educational Institution
- Country Of Registered Address
- Austria
Related trials
Other published trials that may interest you.